Listed

Standard Biotools Inc.: Form 10-Q for the period ended Jun 30, 2011

Filed with the SEC on Aug 9, 2011 and accepted by EDGAR at Aug 9, 2011, 17:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2011-04-01 to 2011-06-30$10.6mus-gaap:Revenues
Revenue6 months2011-01-01 to 2011-06-30$19.3mus-gaap:Revenues
Cost of revenue3 months2011-04-01 to 2011-06-30$3.0mus-gaap:CostOfGoodsSold
Cost of revenue6 months2011-01-01 to 2011-06-30$5.9mus-gaap:CostOfGoodsSold
Research and development3 months2011-04-01 to 2011-06-30$3.4mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2011-01-01 to 2011-06-30$6.6mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2011-04-01 to 2011-06-30$7.8mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2011-01-01 to 2011-06-30$15.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2011-04-01 to 2011-06-30−$6.7mus-gaap:OperatingIncomeLoss
Operating income6 months2011-01-01 to 2011-06-30−$11.5mus-gaap:OperatingIncomeLoss
Interest expense3 months2011-04-01 to 2011-06-30$512.0kus-gaap:InterestExpense
Interest expense6 months2011-01-01 to 2011-06-30$2.3mus-gaap:InterestExpense
Income tax3 months2011-04-01 to 2011-06-30$62.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2011-01-01 to 2011-06-30$110.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2011-04-01 to 2011-06-30−$7.2mus-gaap:NetIncomeLoss
Net income6 months2011-01-01 to 2011-06-30−$14.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2011-04-01 to 2011-06-30−$0.36us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2011-01-01 to 2011-06-30−$1.58us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2011-01-01 to 2011-06-30−$12.9mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2011-01-01 to 2011-06-30$714.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2011-06-30$10.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-06-30$81.0mus-gaap:AssetsCurrent
Total assetsAt period end2011-06-30$85.7mus-gaap:Assets
Current liabilitiesAt period end2011-06-30$17.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2011-06-30$23.4mus-gaap:Liabilities
Long-term debtAt period end2011-06-30$4.7mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2011-06-30$8.3mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2011-06-30$62.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-11-216694. Last ingested by Listed: Nov 5, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.